Polymorphisms in genes encoding pro-inflammatory cytokines have shown to increase the risk of gastric cancer, specifically interleukin-1β (IL1B-511/31, interleukin-1 receptor antagonist (IL1RN*2), and tumour necrosis factor A (TNFA-308) [2–6]. The gene discussed is IL1RN; the disease is gastric cancer.